My Quote Request
6505-01-017-2387
20 Products
VISTARIL
HYDROXYZINE PAMOATE CAPSULES,USP
NSN, MFG P/N
6505010172387
NSN
6505-01-017-2387
VISTARIL
HYDROXYZINE PAMOATE CAPSULES,USP
NSN, MFG P/N
6505010172387
NSN
6505-01-017-2387
MFG
PFIZER INC. DBA PFIZER
Description
(NON-CORE DATA) UNIT PACKAGE TYPE: BOX
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS HYDROXYZINE HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 10.000
CAPSULE TYPE: ANY ACCEPTABLE
FEATURES PROVIDED: INDIVIDUALLY SEALED
PRIMARY CONTAINER TYPE: STRIP
THERAPEUTIC EQUIVALENT: RATED AB
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00026-3092-30
CLOTRIMAZOLE TOPICAL SOLUTION,USP
NSN, MFG P/N
6505010165675
NSN
6505-01-016-5675
NDC00026-3092-30
CLOTRIMAZOLE TOPICAL SOLUTION,USP
NSN, MFG P/N
6505010165675
NSN
6505-01-016-5675
MFG
BAYER PHARMACEUTICALS CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: PERCENTAGE W/V CLOTRIMAZOLE ACTIVE INGREDIENT 1.000
ADMINISTRATION: TOPICAL
DEFINITIVE GOVERNMENT SPEC/STD REFERENCE: MA-136-79
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CLOTRIMAZOLE TOPICAL SOLUTION USP 30 ML BT
MANUFACTURERS CODE: 24065
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPEC/STD CONTROLLING DATA:
Related Searches:
NDC00085-0182-04
CLOTRIMAZOLE TOPICAL SOLUTION,USP
NSN, MFG P/N
6505010165675
NSN
6505-01-016-5675
NDC00085-0182-04
CLOTRIMAZOLE TOPICAL SOLUTION,USP
NSN, MFG P/N
6505010165675
NSN
6505-01-016-5675
MFG
SCHERING LABORATORIES INSTITUTIONAL SALES DEPT K-11-3 L-5
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: PERCENTAGE W/V CLOTRIMAZOLE ACTIVE INGREDIENT 1.000
ADMINISTRATION: TOPICAL
DEFINITIVE GOVERNMENT SPEC/STD REFERENCE: MA-136-79
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CLOTRIMAZOLE TOPICAL SOLUTION USP 30 ML BT
MANUFACTURERS CODE: 24065
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPEC/STD CONTROLLING DATA:
Related Searches:
NDC00093-0248-31
CLOTRIMAZOLE TOPICAL SOLUTION,USP
NSN, MFG P/N
6505010165675
NSN
6505-01-016-5675
NDC00093-0248-31
CLOTRIMAZOLE TOPICAL SOLUTION,USP
NSN, MFG P/N
6505010165675
NSN
6505-01-016-5675
MFG
LEMMON CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: PERCENTAGE W/V CLOTRIMAZOLE ACTIVE INGREDIENT 1.000
ADMINISTRATION: TOPICAL
DEFINITIVE GOVERNMENT SPEC/STD REFERENCE: MA-136-79
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CLOTRIMAZOLE TOPICAL SOLUTION USP 30 ML BT
MANUFACTURERS CODE: 24065
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPEC/STD CONTROLLING DATA:
Related Searches:
132-0211-01
EVACUANT KIT,BOWEL
NSN, MFG P/N
6505010167168
NSN
6505-01-016-7168
MFG
FLEET COMPANY INCORPORATED C. B. DBA FLEET
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: PHOSPHO-SODA,1.5 OZ BOTTLE,BISACODYL TABLETS,4,BICACODYL SUPPOSITORY,1
Related Searches:
NDC00641-1510-36
SODIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505010167313
NSN
6505-01-016-7313
NDC00641-1510-36
SODIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505010167313
NSN
6505-01-016-7313
MFG
ELKINS-SINN INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.900 PERCENTAGE, W/V SODIUM CHLORIDE ACTIVE INGREDIENT
III THERAPEUTIC EQUIVALENT: ELKINS-SINN,INC.
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: AMPUL
Related Searches:
ESKALITH
LITHIUM CARBONATE CAPSULES,USP
NSN, MFG P/N
6505010167746
NSN
6505-01-016-7746
ESKALITH
LITHIUM CARBONATE CAPSULES,USP
NSN, MFG P/N
6505010167746
NSN
6505-01-016-7746
MFG
GLAXOSMITHKLINE HOLDINGS AMERICAS INC. DIV SMITHKLINE BEECHAM CORPORATION
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 0.210 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 6
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 4.000 POUNDS
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.035 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.68 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS LITHIUM CARBONATE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 500.000
CAPSULE TYPE: HARD
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LITHIUM CARBONATE CAPSULES USP 300MG 500S BT
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 500
Related Searches:
NDC00007-4007-25
LITHIUM CARBONATE CAPSULES,USP
NSN, MFG P/N
6505010167746
NSN
6505-01-016-7746
NDC00007-4007-25
LITHIUM CARBONATE CAPSULES,USP
NSN, MFG P/N
6505010167746
NSN
6505-01-016-7746
MFG
GLAXOSMITHKLINE HOLDINGS AMERICAS INC. DIV SMITHKLINE BEECHAM CORPORATION
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 0.210 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 6
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 4.000 POUNDS
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.035 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.68 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS LITHIUM CARBONATE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 500.000
CAPSULE TYPE: HARD
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LITHIUM CARBONATE CAPSULES USP 300MG 500S BT
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 500
Related Searches:
NDC00089-0231-10
ORPHENADRINE CITRATE,ASPIRIN,AND CAFFEINE TABLETS
NSN, MFG P/N
6505010168767
NSN
6505-01-016-8767
NDC00089-0231-10
ORPHENADRINE CITRATE,ASPIRIN,AND CAFFEINE TABLETS
NSN, MFG P/N
6505010168767
NSN
6505-01-016-8767
MFG
3M COMPANY HEALTH CARE/MFG
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 385.000 MILLIGRAMS ASPIRIN ACTIVE INGREDIENT AND 30.000 MILLIGRAMS CAFFEINE ACTIVE INGREDIENT AND 25.000 MILLIGRAMS ORPHENADRINE CITRATE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: ADMINISTRATION:ORAL NONCHEWABLE;
Related Searches:
NORGESIC
ORPHENADRINE CITRATE,ASPIRIN,AND CAFFEINE TABLETS
NSN, MFG P/N
6505010168767
NSN
6505-01-016-8767
NORGESIC
ORPHENADRINE CITRATE,ASPIRIN,AND CAFFEINE TABLETS
NSN, MFG P/N
6505010168767
NSN
6505-01-016-8767
MFG
3M COMPANY HEALTH CARE/MFG
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 385.000 MILLIGRAMS ASPIRIN ACTIVE INGREDIENT AND 30.000 MILLIGRAMS CAFFEINE ACTIVE INGREDIENT AND 25.000 MILLIGRAMS ORPHENADRINE CITRATE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: ADMINISTRATION:ORAL NONCHEWABLE;
Related Searches:
NDC00409-6648-02
DEXTROSE INJECTION,USP
NSN, MFG P/N
6505010170338
NSN
6505-01-017-0338
NDC00409-6648-02
DEXTROSE INJECTION,USP
NSN, MFG P/N
6505010170338
NSN
6505-01-017-0338
MFG
HOSPIRA INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DEXTROSE INJECTION USP 50% 50ML AMPUL 25S BX
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: AMPUL
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
NDC00054-4189-25
DIHYDROTACHYSTEROL TABLETS,USP
NSN, MFG P/N
6505010170341
NSN
6505-01-017-0341
NDC00054-4189-25
DIHYDROTACHYSTEROL TABLETS,USP
NSN, MFG P/N
6505010170341
NSN
6505-01-017-0341
MFG
BOEHRINGER INGELHEIM ROXANE INC. DIV SUB OF BOEHRINGER INGELHEIM CORP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.200 MILLIGRAMS DIHYDROTACHYSTEROL ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DIHYDROTACHYSTEROL TABLETS USP 0.2MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,ROSANE LABS
Related Searches:
NDC00172-2959-60
ERGOLOID MESYLATES TABLETS,USP
NSN, MFG P/N
6505010171626
NSN
6505-01-017-1626
NDC00172-2959-60
ERGOLOID MESYLATES TABLETS,USP
NSN, MFG P/N
6505010171626
NSN
6505-01-017-1626
MFG
ZENITH LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.333 MILLIGRAMS DIHYDROERGOCORNINE MESYLATE ACTIVE INGREDIENT AND 0.333 MILLIGRAMS DIHYDROERGOCRISTINE MESYLATE ACTIVE INGREDIENT AND 0.333 MILLIGRAMS DIHYDROERGOCRYPTINE MESYLATE ACTIVE INGREDIENT
ADMINISTRATION: SUBLINGUAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ERGOLOID MESYLATES TABLETS USP 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
16005-PX
POTASSIUM PHOSPHATES INJECTION,USP
NSN, MFG P/N
6505010172386
NSN
6505-01-017-2386
16005-PX
POTASSIUM PHOSPHATES INJECTION,USP
NSN, MFG P/N
6505010172386
NSN
6505-01-017-2386
MFG
INVENEX LABORATORIES LIFE TECHNOLOGIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 4.400 MILLIEQUIVALENTS POTASSIUM PER MILLILITER AND 3.000 MILLIMOLES PHOSPHATE PER MILLILITER
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: 5 ML. FILL IN A 10 ML. VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
NDC00467-0160-25
POTASSIUM PHOSPHATES INJECTION,USP
NSN, MFG P/N
6505010172386
NSN
6505-01-017-2386
NDC00467-0160-25
POTASSIUM PHOSPHATES INJECTION,USP
NSN, MFG P/N
6505010172386
NSN
6505-01-017-2386
MFG
INVENEX LABORATORIES LIFE TECHNOLOGIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 4.400 MILLIEQUIVALENTS POTASSIUM PER MILLILITER AND 3.000 MILLIMOLES PHOSPHATE PER MILLILITER
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: 5 ML. FILL IN A 10 ML. VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
NDC00469-8600-30
POTASSIUM PHOSPHATES INJECTION,USP
NSN, MFG P/N
6505010172386
NSN
6505-01-017-2386
NDC00469-8600-30
POTASSIUM PHOSPHATES INJECTION,USP
NSN, MFG P/N
6505010172386
NSN
6505-01-017-2386
MFG
LYPHOMED INC DIV OF FUJISAWA USA INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 4.400 MILLIEQUIVALENTS POTASSIUM PER MILLILITER AND 3.000 MILLIMOLES PHOSPHATE PER MILLILITER
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: 5 ML. FILL IN A 10 ML. VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
2747
HYDROXYZINE PAMOATE CAPSULES,USP
NSN, MFG P/N
6505010172387
NSN
6505-01-017-2387
2747
HYDROXYZINE PAMOATE CAPSULES,USP
NSN, MFG P/N
6505010172387
NSN
6505-01-017-2387
MFG
PFIZER INC. DBA PFIZER
Description
(NON-CORE DATA) UNIT PACKAGE TYPE: BOX
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS HYDROXYZINE HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 10.000
CAPSULE TYPE: ANY ACCEPTABLE
FEATURES PROVIDED: INDIVIDUALLY SEALED
PRIMARY CONTAINER TYPE: STRIP
THERAPEUTIC EQUIVALENT: RATED AB
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00069-5410-41
HYDROXYZINE PAMOATE CAPSULES,USP
NSN, MFG P/N
6505010172387
NSN
6505-01-017-2387
NDC00069-5410-41
HYDROXYZINE PAMOATE CAPSULES,USP
NSN, MFG P/N
6505010172387
NSN
6505-01-017-2387
MFG
PFIZER INC. DBA PFIZER
Description
(NON-CORE DATA) UNIT PACKAGE TYPE: BOX
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS HYDROXYZINE HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 10.000
CAPSULE TYPE: ANY ACCEPTABLE
FEATURES PROVIDED: INDIVIDUALLY SEALED
PRIMARY CONTAINER TYPE: STRIP
THERAPEUTIC EQUIVALENT: RATED AB
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC47679-0226-35
HYDROXYZINE PAMOATE CAPSULES,USP
NSN, MFG P/N
6505010172387
NSN
6505-01-017-2387
NDC47679-0226-35
HYDROXYZINE PAMOATE CAPSULES,USP
NSN, MFG P/N
6505010172387
NSN
6505-01-017-2387
MFG
BAXTER HEALTHCARE CORP PHARMACEUTICALS DIV
Description
(NON-CORE DATA) UNIT PACKAGE TYPE: BOX
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS HYDROXYZINE HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 10.000
CAPSULE TYPE: ANY ACCEPTABLE
FEATURES PROVIDED: INDIVIDUALLY SEALED
PRIMARY CONTAINER TYPE: STRIP
THERAPEUTIC EQUIVALENT: RATED AB
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC51079-0077-20
HYDROXYZINE PAMOATE CAPSULES,USP
NSN, MFG P/N
6505010172387
NSN
6505-01-017-2387
NDC51079-0077-20
HYDROXYZINE PAMOATE CAPSULES,USP
NSN, MFG P/N
6505010172387
NSN
6505-01-017-2387
MFG
UDL LABORATORIES INC
Description
(NON-CORE DATA) UNIT PACKAGE TYPE: BOX
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS HYDROXYZINE HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 10.000
CAPSULE TYPE: ANY ACCEPTABLE
FEATURES PROVIDED: INDIVIDUALLY SEALED
PRIMARY CONTAINER TYPE: STRIP
THERAPEUTIC EQUIVALENT: RATED AB
TOTAL PRIMARY CONTAINER QUANTITY: 10